Pacira BioSciences Inc.

NAS: PCRX

GO
/marketstate/country/us

After Hours

/zigman2/quotes/202929053/composite

$

51.66

Change

0.00 0.00%

Volume

Volume 57,494

Oct 27, 2021, 5:25 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/202929053/composite

Previous close

$ 52.41

$ 51.66

Change

-0.75 -1.43%

Day low

Day high

$51.00

$52.64

Open
Open: 52.28

52 week low

52 week high

$45.05

$80.00

Open

Market cap

$2.33B

Average volume

464,513

P/E ratio

13.22

Rev. per Employee

$688,537

EPS

3.91

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/pcrx

MarketWatch News on PCRX

  1. Pacira Biosciences to acquire Flexion Therapeutics for $8.50 a share in cash, pulse CVR worth up to $8 a share

    7:03 a.m. Oct. 11, 2021

    - Ciara Linnane

  2. Flexion shares soar 39% premarket

    7:04 a.m. Oct. 11, 2021

    - Ciara Linnane

  3. Tax Time Is Coming. How Stocks With Losses Offset Capital Gains.

    9:03 p.m. Oct. 10, 2021

    - Barron's Online

  4. Pacira BioSciences upgraded to overweight from neutral at J.P. Morgan

    7:54 a.m. July 26, 2021

    - Tomi Kilgore

  5. Biotech stocks are a buy — especially these 18 picks

    2:02 p.m. March 13, 2021

    - Michael Brush

  6. Pacira BioSciences started at buy with $60 stock price target at SunTrust RH

    8:33 a.m. Jan. 24, 2020

    - Tomi Kilgore

  7. Sachem Head Capital Says A Split-Up Eagle Will Fly

    9:30 p.m. July 12, 2019

    - Barron's Online

  8. Pacira Pharmaceuticals reiterated as sell at Stifel

    8:36 a.m. March 8, 2019

    - Ciara Linnane

  9. Resolute’s Resolve

    8:00 p.m. Oct. 26, 2018

    - Barron's Online

  10. Pacira Pharmaceuticals started at neutral with $47 stock price target at J.P. Morgan

    9:12 a.m. Dec. 18, 2017

    - Tomi Kilgore

  11. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/pcrx

Other News on PCRX

  1. Flexion Therapeutics: Bullish On The Buyout

    9:24 a.m. Oct. 23, 2021

    - Seeking Alpha

  2. Why Pacira Biosciences Stock Sank Today

    3:56 p.m. Oct. 4, 2021

    - Motley Fool

  3. Pacira BioSciences: Attractive Capital Gain Odds Next 3 Months

    1:13 p.m. Sept. 17, 2021

    - Seeking Alpha

  4. Pacira Biosciences (PCRX) Investor Presentation - Slideshow

    10:24 a.m. Aug. 13, 2021

    - Seeking Alpha

  5. Pacira BioSciences nabs prelim July net product sales of $42.1M

    8:43 a.m. Aug. 10, 2021

    - Seeking Alpha

  6. 10-Q: PACIRA BIOSCIENCES, INC.

    11:39 a.m. Aug. 3, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  7. Loading more headlines...
/news/pressrelease/company/us/pcrx

Press Releases on PCRX

  1. ImmuneID Appoints Veteran Biotech Executive James S. Scibetta as CEO

    8:00 a.m. Sept. 21, 2021

    - BusinessWire - BZX

  2. Loading more headlines...

Rates »

Trending Tickers
  • /zigman2/quotes/200467500/composite NVDA+6.01%
  • /zigman2/quotes/200164174/composite SNOA+85.40%
  • /zigman2/quotes/202092269/composite ENSC+35.46%
  • /zigman2/quotes/226465160/composite ALF-14.72%
  • /zigman2/quotes/207732364/composite MSFT+1.66%
X
Powered by StockTwits
Link to MarketWatch's Slice.